Print  |  Email
Laboratory: Clinical Immunology
Test Name:
ANTI-NUCLEAR ANTIBODY PROFILE - (S)
Test Code: REFLEX FROM HEP 2 [ORDERABLE BY RHEUMATOLOGY ONLY]
Clinical Information:
Test Indications: 
Evaluating patients with signs and symptoms of a connective tissue disease in whom the test for antinuclear antibodies is positive.  Testing is reflexed based on known pattern/antigen associations.

Testing is not useful in patients without demonstrable anti-nuclear antibodies.
 
ANA Pattern (≥1:160 Titre)  dsDNA  Profile
  NUCLEAR PATTERN
 Homogeneous    X    X
 Speckled    X   X
 Centromere    X
 Nucleolar    X
 PCNA    X
  Cytoplasmic Pattern
 Cyto-Speckled    X
 Cyto-AMA    X


Visit the International Consensus on Antinuclear Antibody Patterns website for additional information about pattern and disease/antigen associations.



 

Collection Devices:
Specimen Required:

Alternate Names: 
Anti-ENA (Antibodies to Extractable Nuclear Antigens)
Anti-La
Anti-Ribonuclear Protein
Anti-RNP (Anti-Ribonucleoprotein)
Anti-Ro
Anti-Sjogren's Syndrome
Anti-Sm (Smith)
Anti-Smith (SM) Antigen
Anti-SSA (Anti-Sjogren's Syndrome A)
Anti-SSB (Anti-Sjogren's Syndrome B)
Anti-U(1)RNP (Anti-Ribonucleoprotein)
Antibodies to Extractable Nuclear Antigens
Autoantibodies to Jo 1 Antigen
Autoantibodies to Sm (Smith)
Autoantibodies to SSA (Ro)
Autoantibodies to SSB (La)
Autoantibodies to U(1)RNP
CENP B
Centromere Protein B
DFS70
ENA (Extractable Nuclear Antigens), Anti
ENA
Extractable Nuclear Antigens, Anti
Histidyl-tRNA Synthetase Antibodies
Histones
RNP (Anti-RNP)
Ro (Anti-SSA)
Scl 70 Antibodies
Sjogren's Syndrome
Sm (Anti-Sm) (Smith)
Sm (Smith) Autoantibodies
Smith Antigen, Anti
SmRNP Autoantibodies
SSA (Anti-SSA)
SSB (Anti-SSB)
Topoisomerase 1 Antibodies
U(1)RNP (Ribonucleoprotein) Autoantibodies
Autoantibodies to Scl 70 Antigen
Jo 1 Antibodies
LA (Anti-La)
La (Anti-SSB)
Nucleosomes
PCNA
PM-Scl
Ribonucleoprotein (RNP) Autoantibodies
Ribosomal P

Specimen Stability:
Refigerated: 14 days
Frozen: 30 days
Referral:

Testing Laboratory (MB): St. Boniface Hospital Immunology Laboratory 
Requisition:
Reference Values:
Reference Intervals: Negative
A negative result does not necessarily exclude autoimmune disease.  Positive results should not be interpreted in isolation and must be correlated with relevant clinical findings. 

Method of Analysis:
The Line Immunoassay (LIA) provides qualitative in vitro determination of human autoantibodies of the IgG class to 15 different antigens nRNP, Sm, SS-A, Ro-52, SS-B, Scl-70, PM-Scl, Jo-1, CENP B, PCNA, nucleosomes, histones, ribosomal P-protein, AMA-M2 and DFS70 in serum.

References: 
EUROIMMUN EUROLINE ANA Profile 3 plus DFS70 (IgG) Test Instruction DL_1590-30G_A_UK_C04.doc Version: 01/02/2019.
Availability:
Weekdays
TAT: Within 4 days
See Also:
More Information:
Interpretation & Assay Interferences: 
Positive results will be accompanied by an intensity (Weak, Moderate, Strong)
 
Autoantibodies AgainstAutoimmune diseasePrevalence
nRNP/SmMCTD95%
SmSLE5% - 40%
SS-ASS or SLE
Neonatal lupus erythematosus
40% - 95% or 20% - 60%
95% - 100%
Ro-52SS or SLE
SSc or idiopathic inflammatory myopathy
70% - 90% or 40% - 60%
20% or 20% - 40%
SS-BSS or SLE
Neonatal lupus erythematosus
40% - 95% or 10% - 20%
75%
Scl-70SSc
Diffuse or limited form of SSc
25% - 75%
40% - 65% or 5% - 15%
PM-SclSSc including overlap syndrome
PM/SSc overlap syndrome
SSc (anti-PM-Scl75 positive)
SSc (anti-PM-Scl100 positive)
10% - 20% or 5% - 20%
18%
24% - 50%
7%
Jo-1Myositis (polymyositis/dermatomyositis)25% - 35%
CENP BSSc - limited form or SSc - diffuse form
PBC
80% - 95% or 8%
10% - 30%
PCNASLE3%
NucleosomesSLE40% - 70%
HistonesDrug-induced SLE
SLE or RA
95% - 100%
50% or 15% - 50%
Rib P ProteinSLE10%
AMA-M2PBC or other chronic liver diseases
SSc
up to 96% or 30%
7% - 25%
DFS70Atopic dermatitis
Rheumatic diseases
4% - 10%
5% - 10%